Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Alexander, Bershadskiy"'
Publikováno v:
European Journal of Case Reports in Internal Medicine (2024)
Anagrelide is a medication primarily used to manage thrombocytosis, an abnormal increase in platelet levels in the blood. It is often prescribed for patients with myeloproliferative disorders, such as essential thrombocythaemia (ET). Given the height
Externí odkaz:
https://doaj.org/article/fb172816d67741c891a7982ae9d5ad22
Publikováno v:
Journal of Community Hospital Internal Medicine Perspectives, Vol 11, Iss 6, Pp 832-838 (2021)
Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia characterized by a translocation of chromosomes 15 and 17, creating an alternation in the retinoic acid receptor-alpha (RAR-alpha) gene. This leads to excessive medull
Externí odkaz:
https://doaj.org/article/565611e1f0c746648ce094ced13eda14
Autor:
Sam Ngu, Divya Asti, Gautam Valecha, Nishitha Thumallapally, Manisha Pant, Alexander Bershadskiy
Publikováno v:
Clinical Case Reports, Vol 7, Iss 9, Pp 1702-1708 (2019)
Abstract Due to the rarity and fulminant nature of the condition, there are limited data driving dialogue for optimal treatment strategies for plasma cell leukemia (PCL). Additionally, the current diagnostic definition of PCL has not been prospective
Externí odkaz:
https://doaj.org/article/40f61189a908479ca8011820102745d2
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/9f305414aad84fb9843e8a3714728982
Publikováno v:
Journal of Community Hospital Internal Medicine Perspectives, Vol 11, Iss 6, Pp 832-838 (2021)
Journal of Community Hospital Internal Medicine Perspectives
article-version (VoR) Version of Record
Journal of Community Hospital Internal Medicine Perspectives
article-version (VoR) Version of Record
Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia characterized by a translocation of chromosomes 15 and 17, creating an alternation in the retinoic acid receptor-alpha (RAR-alpha) gene. This leads to excessive medull
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c5058d6c786a8e6cc59cfb6b7421921
https://doaj.org/article/565611e1f0c746648ce094ced13eda14
https://doaj.org/article/565611e1f0c746648ce094ced13eda14
Publikováno v:
Asian Journal of Andrology, Vol 16, Iss 3, Pp 387-400 (2014)
Suppression of gonadal testosterone synthesis represents the standard first line therapy for treatment of metastatic prostate cancer. However, in the majority of patients who develop castration-resistant prostate cancer (CRPC), it is possible to dete
Externí odkaz:
https://doaj.org/article/a52f2be9f22949439f381b549de3511a
Autor:
Kira, MacDougall, Muhammad Rafay Khan, Niazi, Jeff, Hosry, Sylvester, Homsy, Alexander, Bershadskiy
Publikováno v:
ONCOLOGY.
Systemic inflammation has long been associated with poor outcomes in many types of solid tumors. Peripheral blood biomarkers, such as absolute lymphocyte count (ALC) and the ratio of absolute neutrophil count to absolute lymphocyte count (ANC/ALC), h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b37da8c817110160e4e0080ab07138a3
https://doi.org/10.46883/25920954
https://doi.org/10.46883/25920954
Autor:
Muhammad, Niazi, Abdullah, Jahangir, Syeda, Sahra, Saud, Sattar, Divya, Asti, Alexander, Bershadskiy
Publikováno v:
Oncology (Williston Park, N.Y.). 35(11)
Background: PARP inhibitors have been recently approved by the FDA for the treatment of metastatic castration-resistant prostate cancer (mCRPC). Their effectiveness is seen when used with androgen deprivation therapy in patients with or without delet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e9e85ffc0077c81ab62bdd96053dd24c
https://pubmed.ncbi.nlm.nih.gov/35088974
https://pubmed.ncbi.nlm.nih.gov/35088974
Autor:
Alexander Bershadskiy, Sam Ngu, Nishitha Thumallapally, Gautam Valecha, Divya Asti, Manisha Pant
Publikováno v:
Clinical Case Reports, Vol 7, Iss 9, Pp 1702-1708 (2019)
Clinical Case Reports
Clinical Case Reports
Due to the rarity and fulminant nature of the condition, there are limited data driving dialogue for optimal treatment strategies for plasma cell leukemia (PCL). Additionally, the current diagnostic definition of PCL has not been prospectively studie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ef29133aba78936764a47d1565a82bc
https://doaj.org/article/40f61189a908479ca8011820102745d2
https://doaj.org/article/40f61189a908479ca8011820102745d2
Publikováno v:
Surgical Neurology International. 13:181
Background: Primary central nervous system lymphoma (PCNSL) is an aggressive extranodal subtype of nonHodgkin’s lymphoma. Ventricle-predominant PCNSL, arising in the CNS ventricular system, is a rare entity. In over 90% of cases, PCNSL is classifie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70989eafbd4f2da27183d7c132c0b1e7
https://doi.org/10.25259/sni_54_2022
https://doi.org/10.25259/sni_54_2022